Cargando…

Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements

BACKGROUND: Double-hit lymphoma is a complex and highly aggressive sub-type of B-cell lymphoma, which has recently been classified and is an area of active research interest due to the poor prognosis for patients with this disease. It is characterized by the presence of both an activating MYC chromo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hooper, Sean D, Jiao, Xiang, Sundström, Elisabeth, Rehman, Farah L, Tellgren-Roth, Christian, Sjöblom, Tobias, Cavelier, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534606/
https://www.ncbi.nlm.nih.gov/pubmed/23171647
http://dx.doi.org/10.1186/1756-0500-5-648
_version_ 1782475365375016960
author Hooper, Sean D
Jiao, Xiang
Sundström, Elisabeth
Rehman, Farah L
Tellgren-Roth, Christian
Sjöblom, Tobias
Cavelier, Lucia
author_facet Hooper, Sean D
Jiao, Xiang
Sundström, Elisabeth
Rehman, Farah L
Tellgren-Roth, Christian
Sjöblom, Tobias
Cavelier, Lucia
author_sort Hooper, Sean D
collection PubMed
description BACKGROUND: Double-hit lymphoma is a complex and highly aggressive sub-type of B-cell lymphoma, which has recently been classified and is an area of active research interest due to the poor prognosis for patients with this disease. It is characterized by the presence of both an activating MYC chromosomal translocation and a simultaneous additional oncogenic translocation, often of the BCL2 gene. Recently, a cell line was established from a patient with this complex lymphoma and analyzed using conventional tools revealing it contains both MYC and BCL2 translocation events. FINDINGS: In this work, we reanalyzed the genome of the cell line using next generation whole genome sequencing technology in order to catalogue translocations, insertions and deletions which may contribute to the pathology of this lymphoma type. CONCLUSIONS: We describe the cell line in much greater detail, and pinpoint the exact locations of the chromosomal breakpoints. We also find several rearrangements within cancer-associated genes, which were not found using conventional tools, suggesting that high throughput sequencing may reveal novel targets for therapy, which could be used concurrently with existing treatments.
format Online
Article
Text
id pubmed-3534606
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35346062013-01-03 Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements Hooper, Sean D Jiao, Xiang Sundström, Elisabeth Rehman, Farah L Tellgren-Roth, Christian Sjöblom, Tobias Cavelier, Lucia BMC Res Notes Short Report BACKGROUND: Double-hit lymphoma is a complex and highly aggressive sub-type of B-cell lymphoma, which has recently been classified and is an area of active research interest due to the poor prognosis for patients with this disease. It is characterized by the presence of both an activating MYC chromosomal translocation and a simultaneous additional oncogenic translocation, often of the BCL2 gene. Recently, a cell line was established from a patient with this complex lymphoma and analyzed using conventional tools revealing it contains both MYC and BCL2 translocation events. FINDINGS: In this work, we reanalyzed the genome of the cell line using next generation whole genome sequencing technology in order to catalogue translocations, insertions and deletions which may contribute to the pathology of this lymphoma type. CONCLUSIONS: We describe the cell line in much greater detail, and pinpoint the exact locations of the chromosomal breakpoints. We also find several rearrangements within cancer-associated genes, which were not found using conventional tools, suggesting that high throughput sequencing may reveal novel targets for therapy, which could be used concurrently with existing treatments. BioMed Central 2012-11-22 /pmc/articles/PMC3534606/ /pubmed/23171647 http://dx.doi.org/10.1186/1756-0500-5-648 Text en Copyright ©2012 Hooper et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Report
Hooper, Sean D
Jiao, Xiang
Sundström, Elisabeth
Rehman, Farah L
Tellgren-Roth, Christian
Sjöblom, Tobias
Cavelier, Lucia
Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements
title Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements
title_full Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements
title_fullStr Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements
title_full_unstemmed Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements
title_short Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements
title_sort sequence based analysis of u-2973, a cell line established from a double-hit b-cell lymphoma with concurrent myc and bcl2 rearrangements
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534606/
https://www.ncbi.nlm.nih.gov/pubmed/23171647
http://dx.doi.org/10.1186/1756-0500-5-648
work_keys_str_mv AT hooperseand sequencebasedanalysisofu2973acelllineestablishedfromadoublehitbcelllymphomawithconcurrentmycandbcl2rearrangements
AT jiaoxiang sequencebasedanalysisofu2973acelllineestablishedfromadoublehitbcelllymphomawithconcurrentmycandbcl2rearrangements
AT sundstromelisabeth sequencebasedanalysisofu2973acelllineestablishedfromadoublehitbcelllymphomawithconcurrentmycandbcl2rearrangements
AT rehmanfarahl sequencebasedanalysisofu2973acelllineestablishedfromadoublehitbcelllymphomawithconcurrentmycandbcl2rearrangements
AT tellgrenrothchristian sequencebasedanalysisofu2973acelllineestablishedfromadoublehitbcelllymphomawithconcurrentmycandbcl2rearrangements
AT sjoblomtobias sequencebasedanalysisofu2973acelllineestablishedfromadoublehitbcelllymphomawithconcurrentmycandbcl2rearrangements
AT cavelierlucia sequencebasedanalysisofu2973acelllineestablishedfromadoublehitbcelllymphomawithconcurrentmycandbcl2rearrangements